The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Tafani, Marco ^a   Sansone, Luigi ^b   Limana, Federica ^c   Arcangeli, Tania ^a   De Santis, Elena ^a   Polese, Milena ^a   Fini, Massimo ^b   Russo, Matteo A ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; METADATA; PHYSIOLOGICAL MODELS; PHYSIOLOGY; TUMORS;

BENEFICIAL EFFECTS; COMPARTMENTATION; MALIGNANT PROGRESSION; MALIGNANT TUMORS; NATURAL HISTORY; PATHOLOGICAL EFFECTS; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR GENES;

DISEASES;

ACUTE PHASE PROTEIN; ALARMIN; ARACHIDONATE 5 LIPOXYGENASE; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; CYCLOOXYGENASE 2; CYTOKINE; CYTOKINE RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRIX METALLOPROTEINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; SUPEROXIDE; SUPPRESSOR OF CYTOKINE SIGNALING; TELOMERASE; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADAPTATION; BIOLOGICAL FUNCTIONS; CANCER GROWTH; CANCER RESISTANCE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG RESISTANCE; ENZYME ACTIVATION; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HYPOXIA; INFLAMMATION; LIPID PEROXIDATION; MALIGNANT TRANSFORMATION; METABOLISM; METASTASIS; NONHUMAN; NUCLEAR REPROGRAMMING; ONCOGENE; OXIDATION REDUCTION STATE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; SURVIVAL FACTOR; TRANSFORMED CELL; TUMOR INVASION; TUMOR METABOLISM; TUMOR NECROSIS; TUMOR SUPPRESSOR GENE; ANIMAL; CARCINOGENESIS; COMPLICATION; DISEASE COURSE; PATHOLOGY;

ANIMALS; CARCINOGENESIS; DISEASE PROGRESSION; HUMANS; HYPOXIA; INFLAMMATION; REACTIVE OXYGEN SPECIES; SIRTUINS;

EID: 84954288936     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/3907147     Document Type: Review

References (173)

1. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, "Oxidative stress, inflammation, and cancer: how are they linked?" Free Radical Biology and Medicine, vol. 49, no. 11, pp. 1603-1616, 2010.
2. M. Rinnerthaler, J. Bischof, M. Streubel, A. Trost, and K. Richter, "Oxidative stress in aging human skin, " Biomolecules, vol. 5, no. 2, pp. 545-589, 2015.
3. K. Maiese, "New insights for oxidative stress and diabetes mellitus, " Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 875961, 17 pages, 2015.
4. W. Li, L. Wang, W. Huang et al., "Inhibition of ROS and inflammation by an imidazopyridine derivative X22 attenuate high fat diet-induced arterial injuries, " Vascular Pharmacology, vol. 72, pp. 153-162, 2015.
5. C. A. Cobb and M. P. Cole, "Oxidative and nitrative stress in neurodegeneration, " Neurobiology of Disease, 2015.
6. Y. Quan, L. Xia, J. Shao et al., "Adjudin protects rodent cochlear hair cells against gentamicin ototoxicity via the SIRT3-ROS pathway, " Scientific Reports, vol. 5, p. 8181, 2015.
7. S. S. Sabharwal and P. T. Schumacker, "Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?" Nature Reviews Cancer, vol. 14, no. 11, pp. 709-721, 2014.
8. M. M. Briehl, "Oxygen in human health from life to death-an approach to teaching redox biology and signaling to graduate and medical students, " Redox Biology, vol. 11, no. 5, pp. 124-139, 2015.
9. D. Hernández-García, C. D. Wood, S. Castro-Obregón, and L. Covarrubias, "Reactive oxygen species: a radical role in development?" Free Radical Biology and Medicine, vol. 49, no. 2, pp. 130-143, 2010.
10. L. Luzzatto and P. P. Pandolfi, "Causality and chance in the development of cancer, " The New England Journal of Medicine, vol. 373, no. 1, pp. 84-88, 2015.
11. R. Pagliarini, W. Shao, and W. R. Sellers, "Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure, " The EMBO Reports, vol. 16, no. 3, pp. 280-296, 2015.
12. A. M. A. Velez and M. S. Howard, "Tumor-suppressor genes, cell cycle regulatory checkpoints, and the skin, " North American Journal of Medical Sciences, vol. 7, no. 5, pp. 176-188, 2015.
13. H. Wang, X. Zhang, L. Teng, and R. J. Legerski, "DNA damage checkpoint recovery and cancer development, " Experimental Cell Research, vol. 334, no. 2, pp. 350-358, 2015.
14. B. Keith and M. C. Simon, "Hypoxia-inducible factors, stem cells, and cancer, " Cell, vol. 129, no. 3, pp. 465-472, 2007.
15. M. Kondoh, N. Ohga, K. Akiyama et al., "Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment, " PLoS ONE, vol. 8, no. 11, Article ID e80349, 2013.
16. Q.-S. Wang, Y.-M. Zheng, L. Dong, Y.-S. Ho, Z. Guo, and Y.-X. Wang, "Role of mitochondrial reactive oxygen species in hypoxia-dependent increase in intracellular calcium in pulmonary artery myocytes, " Free Radical Biology and Medicine, vol. 42, no. 5, pp. 642-653, 2007.
17. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation, " Cell, vol. 144, no. 5, pp. 646-674, 2011.
18. S.-H. Park, O. Ozden, H. Jiang et al., "Sirt3, mitochondrial ROS, ageing, and carcinogenesis, " International Journal of Molecular Sciences, vol. 12, no. 9, pp. 6226-6239, 2011.
19. D. E. Handy and J. Loscalzo, "Redox regulation of mitochondrial function, " Antioxidants and Redox Signaling, vol. 16, no. 11, pp. 1323-1367, 2012.
20. A. Federico, F. Morgillo, C. Tuccillo, F. Ciardiello, and C. Loguercio, "Chronic inflammation and oxidative stress in human carcinogenesis, " International Journal of Cancer, vol. 121, no. 11, pp. 2381-2386, 2007.
21. F. Jiang, Y. Zhang, and G. J. Dusting, "NADPH oxidasemediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair, " Pharmacological Reviews, vol. 63, no. 1, pp. 218-242, 2011.
22. K. Bedard and K.-H. Krause, "The NOX family of ROSgeneratingNADPHoxidases: physiology and pathophysiology, " Physiological Reviews, vol. 87, no. 1, pp. 245-313, 2007.
23. R. Rathore, Y.-M. Zheng, C.-F. Niu et al., "Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKC signaling axis in pulmonary artery smooth muscle cells, " Free Radical Biology and Medicine, vol. 45, no. 9, pp. 1223-1231, 2008.
24. K. M. Porter, B.-Y. Kang, S. E. Adesina, T. C. Murphy, C. M. Hart, and R. L. Sutliff, "Chronic hypoxia promotes pulmonary artery endothelial cell proliferation through H2O2-induced 5-lipoxygenase, " PLoS ONE, vol. 9, no. 6, Article ID e98532, 2014.
25. R. A. Kramer, J. Zakher, and G. Kim, "Role of the glutathione redox cycle in acquired and de novo multidrug resistance, " Science, vol. 241, no. 4866, pp. 694-697, 1988.
26. W. Zhao, G. Ma, and X. Chen, "Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPKNF-B pathway, " Vascular Pharmacology, vol. 63, no. 3, pp. 162-172, 2014.
27. N. Y. Spencer and J. F. Engelhardt, "The basic biology of redoxosomes in cytokine-mediated signal transduction and implications for disease-specific therapies, " Biochemistry, vol. 53, no. 10, pp. 1551-1564, 2014.
28. K. Roy, Y. Wu, J. L. Meitzler et al., "NADPH oxidases and cancer, " Clinical Science, vol. 128, no. 12, pp. 863-875, 2015.
29. R. Sharma, A. Agarwal, G. Mohanty et al., "Proteomic analysis of seminal fluid from men exhibiting oxidative stress, " Reproductive Biology and Endocrinology, vol. 11, article 85, 15 pages, 2013.
30. S. Kundu, P. Ghosh, S. Datta, A. Ghosh, S. Chattopadhyay, and M. Chatterjee, "Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis, " Free Radical Research, vol. 46, no. 12, pp. 1482-1489, 2012.
31. B. Drukarch, E. Schepens, J. C. Stoof, C. H. Langeveld, and F. L. Van Muiswinkel, "Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species, " Free Radical Biology and Medicine, vol. 25, no. 2, pp. 217-220, 1998.
32. M. Neihörster, M. Inoue, and A. Wendel, "A link between extracellular reactive oxygen and endotoxin-induced release of tumour necrosis factor in vivo, " Biochemical Pharmacology, vol. 43, no. 5, pp. 1151-1154, 1992.
33. B. Nazima, V. Manoharan, and S. Miltonprabu, "Oxidative stress induced by cadmium in the plasma, erythrocytes and lymphocytes of rats: Attenuation by grape seed proanthocyanidins, " Human & Experimental Toxicology, 2015.
34. E. J. Szili, S. H. Hong, and R. D. Short, "On the effect of serum on the transport of reactive oxygen species across phospholipid membranes, " Biointerphases, vol. 10, no. 2, Article ID 029511, 2015.
35. R. M. Cordeiro, "Molecular dynamics simulations of the transport of reactive oxygen species by mammalian and plant aquaporins, " Biochimica et Biophysica Acta, vol. 1850, no. 9, pp. 1786-1794, 2015.
36. J. G. van den Boorn, J. Daßler, C. Coch, M. Schlee, and G. Hartmann, "Exosomes as nucleic acid nanocarriers, " Advanced Drug Delivery Reviews, vol. 65, no. 3, pp. 331-335, 2013.
37. L. O'Driscoll, "Expanding on exosomes and ectosomes in cancer, " The New England Journal of Medicine, vol. 372, no. 24, pp. 2359-2362, 2015.
38. M. Guven, R. Brem, P. Macpherson, M. Peacock, and P. Karran, "Oxidative damage to RPA limits the nucleotide excision repair capacity of human cells, " Journal of Investigative Dermatology, 2015.
39. D. Ziech, R. Franco, A. Pappa, and M. I. Panayiotidis, "Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis, " Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 711, no. 1-2, pp. 167-173, 2011.
40. F. Caputo, R. Vegliante, and L. Ghibelli, "Redox modulation of the DNA damage response, " Biochemical Pharmacology, vol. 84, no. 10, pp. 1292-1306, 2012.
41. J. L. Farber and S. K. El Mofty, "The biochemical pathology of liver cell necrosis, " American Journal of Pathology, vol. 81, no. 1, pp. 237-250, 1975.
42. M. A. Russo, A. Cittadini, A. M. Dani, G. Inesi, and T. Terranova, "An ultrastructural study of calciuminduced degenerative changes in dissociated heart cells, " Journal of Molecular and Cellular Cardiology, vol. 13, no. 3, pp. 265-279, 1981.
43. M. A. Russo, A. B. Kane, and J. L. Farber, "Ultrastructural pathology of phalloidin-intoxicated hepatocytes in the presence and absence of extracellular calcium, " American Journal of Pathology, vol. 109, no. 2, pp. 133-144, 1982.
44. Y.-T. T. Yang, M. Whiteman, and S. P. Gieseg, "HOCl causes necrotic cell death in human monocyte derived macrophages through calcium dependent calpain activation, " Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1823, no. 2, pp. 420-429, 2012.
45. M. Kang, A. Hashimoto, A. Gade, and H. I. Akbarali, "nteraction between hydrogen sulfide-induced sulfhydration and tyrosine nitration in the KATP channel complex, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 308, no. 6, pp. G532-G539, 2015.
46. S. W. Kang, S. Lee, and E. K. Lee, "ROS and energy metabolism in cancer cells: alliance for fast growth, " Archives of Pharmacal Research, vol. 38, no. 3, pp. 338-345, 2015.
47. V. O. Okoh, N. A. Garba, R. B. Penney et al., "Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells, " British Journal of Cancer, vol. 112, no. 10, pp. 1687-1702, 2015.
48. K. Aziz, S. Nowsheen, G. Pantelias, G. Iliakis, V. G. Gorgoulis, and A. G. Georgakilas, "Targeting DNA damage and repair: embracing the pharmacological era for successful cancer therapy, " Pharmacology and Therapeutics, vol. 133, no. 3, pp. 334-350, 2012.
49. U. Weyemi, O. Lagente-Chevallier, M. Boufraqech et al., "ROSgenerating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-inducedDNA damage and subsequent senescence, " Oncogene, vol. 31, no. 9, pp. 1117-1129, 2012.
50. A. Maya-Mendoza, J. Ostrakova, M. Kosar et al., "Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative andDNA replication stress, " Molecular Oncology, vol. 9, no. 3, pp. 601-616, 2015.
51. J. Bourgeais, V. Gouilleux-Gruart, and F. Gouilleux, "Oxidative metabolism in cancer: a STAT affair?" JAK-STAT, vol. 2, no. 4, Article ID e25764, 2013.
52. D. J. Gough, A. Corlett, K. Schlessinger, J. Wegrzyn, A. C. Larner, and D. E. Levy, "Mitochondrial STAT3 supports Rasdependent oncogenic transformation, " Science, vol. 324, no. 5935, pp. 1713-1716, 2009.
53. R. A. Gatenby and R. J. Gillies, "Why do cancers have high aerobic glycolysis?" Nature Reviews Cancer, vol. 4, no. 11, pp. 891-899, 2004.
54. A. Carreau, B. E. Hafny-Rahbi, A. Matejuk, C. Grillon, and C. Kieda, "Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia, " Journal of Cellular and Molecular Medicine, vol. 15, no. 6, pp. 1239-1253, 2011.
55. S. Kovac, P. R. Angelova, K. M. Holmström, Y. Zhang, A. T. Dinkova-Kostova, and A. Y. Abramov, "Nrf2 regulates ROS production by mitochondria and NADPH oxidase, " Biochimica et Biophysica Acta-General Subjects, vol. 1850, no. 4, pp. 794-801, 2015.
56. E. J. Moon and A. Giaccia, "Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment, " Free Radical Biology and Medicine, vol. 79, pp. 292-299, 2015.
57. J. Huang, Y. Xie, X. Sun et al., "DAMPs, ageing, and cancer: the 'DAMP hypothesis', " Ageing Research Reviews, 2014.
58. J.-W. Kang, S.-J. Kim, H.-I. Cho, and S.-M. Lee, "DAMPs activating innate immune responses in sepsis, " Ageing Research Reviews, 2015.
59. M. Jiang, C. Qin, and M. Han, "Primary breast cancer induces pulmonary vascular hyperpermeability and promotes metastasis via theVEGF-PKC pathway, "Molecular Carcinogenesis, 2015.
60. H. Nishi, T. Nakada, S. Kyo, M. Inoue, J. W. Shay, and K. Isaka, "Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT), " Molecular and Cellular Biology, vol. 24, no. 13, pp. 6076-6083, 2004.
61. V. Mucaj, J. E. S. Shay, and M. C. Simon, "Effects of hypoxia and HIFs on cancer metabolism, " International Journal of Hematology, vol. 95, no. 5, pp. 464-470, 2012.
62. M. C. Brahimi-Horn and J. Pouysségur, "Hypoxia in cancer cell metabolism and pH regulation, " Essays in Biochemistry, vol. 43, pp. 165-178, 2007.
63. Y. Kondo, S. Arii, A. Mori, M. Furutani, T. Chiba, and M. Imamura, "Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line, " Clinical Cancer Research, vol. 6, no. 2, pp. 622-630, 2000.
64. M. Drigotas, A. Affolter, W. J. Mann, and J. Brieger, "Reactive oxygen species activation of MAPK pathway results in VEGF upregulation as an undesired irradiation response, " Journal of Oral Pathology and Medicine, vol. 42, no. 8, pp. 612-619, 2013.
65. A. Ahluwalia, M. K. Jones, S. Szabo, and A. S. Tarnawski, "Aberrant, ectopic expression of VEGF and VEGF receptors 1 and 2 in malignant colonic epithelial cells. Implications for these cells growth via an autocrine mechanism, " Biochemical and Biophysical Research Communications, vol. 437, no. 4, pp. 515-520, 2013.
66. C. Romilda, P. Marika, S. Alessandro et al., "Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma, " BMC Cancer, vol. 12, article 177, 2012.
67. N. E. López-Diazguerrero, G. E. Pérez-Figueroa, C. M. Martínez-Garduño et al., "Telomerase activity in response to mild oxidative stress, " Cell Biology International, vol. 36, no. 4, pp. 409-413, 2012.
68. N. Yatabe, S. Kyo, Y. Maida et al., "HIF-1-mediated activation of telomerase in cervical cancer cells, " Oncogene, vol. 23, no. 20, pp. 3708-3715, 2004.
69. G. Saretzki, "Extra-telomeric functions of human telomerase: cancer, mitochondria and oxidative stress, " Current Pharmaceutical Design, vol. 20, no. 41, pp. 6386-6403, 2014.
70. Y.-G. Yoo, M. Hayashi, J. Christensen, and L. E. Huang, "An essential role of the HIF-1alpha-c-Myc axis in malignant progression, " Annals of the New York Academy of Sciences, vol. 1177, pp. 198-204, 2009.
71. S.-W. Lee, H.-K. Jeong, J.-Y. Lee et al., "Hypoxic priming of mESCs accelerates vascular-lineage differentiation through HIF1-mediated inverse regulation of Oct4 and VEGF, " EMBO Molecular Medicine, vol. 4, no. 9, pp. 924-938, 2012.
72. L. Qiang, T. Wu, H.-W. Zhang et al., "HIF-1 is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway, " Cell Death and Differentiation, vol. 19, no. 2, pp. 284-294, 2012.
73. K. Takubo, N. Goda, W. Yamada et al., "Regulation of the HIF-1alpha level is essential for hematopoietic stem cells, " Cell Stem Cell, vol. 7, no. 3, pp. 391-402, 2010.
74. C. N. Im, H. H. Yun, H. J. Yoo, M. J. Park, and J. H. Lee, "Enhancement of SOX-2 expression and ROS accumulation by culture of A172 glioblastoma cells under non-adherent culture conditions, " Oncology Reports, vol. 34, no. 2, pp. 920-928, 2015.
75. M. Maugeri-Saccà, P. Vigneri, and R. De Maria, "Cancer stem cells and chemosensitivity, " Clinical Cancer Research, vol. 17, no. 15, pp. 4942-4947, 2011.
76. J. Chen, Z. Ding, Y. Peng et al., "HIF-1 inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein, " PLoS ONE, vol. 9, no. 6, Article ID e98882, 2014.
77. M. Wartenberg, E. Hoffmann, H. Schwindt et al., "Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids, " FEBS Letters, vol. 579, no. 20, pp. 4541-4549, 2005.
78. G. L. Semenza, B.-H. Jiang, S. W. Leung et al., "Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase a gene promoters contain essential binding sites for hypoxia-inducible factor 1, " The Journal of Biological Chemistry, vol. 271, no. 51, pp. 32529-32537, 1996.
79. L. Tochhawng, S. Deng, S. Pervaiz, and C. T. Yap, "Redox regulation of cancer cell migration and invasion, " Mitochondrion, vol. 13, no. 3, pp. 246-253, 2013.
80. M. Tafani, L. Schito, L. Pellegrini et al., "Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-B, " Carcinogenesis, vol. 32, no. 8, pp. 1167-1175, 2011.
81. R. Kang, W. Hou, Q. Zhang et al., "RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer, " Cell Death and Disease, vol. 5, no. 10, Article IDe1480, 2014.
82. W. Zhang, X. Shi, Y. Peng et al., "HIF-1 promotes epithelialmesenchymal transition and metastasis through direct regulation of ZEB1 in colorectal cancer, " PLoS ONE, vol. 10, no. 6, Article ID e0129603, 2015.
83. D. Rosolen, V. F. Noldin, E. Winter et al., "Intracellular ROS generation mediates maleimide-induced cytotoxicity in leukemia cells, " Anti-Cancer Agents in Medicinal Chemistry, vol. 15, no. 9, pp. 1164-1173, 2015.
84. M. A. Russo, L. Sansone, I. Carnevale et al., "One special question to start with: can HIF/NFkB be a target in inflammation?" Endocrine, Metabolic&Immune Disorders-Drug Targets, vol. 15, no. 3, pp. 171-185, 2015.
85. Y. Miyake and S. Yamasaki, "Sensing necrotic cells, " Advances in Experimental Medicine and Biology, vol. 738, pp. 144-152, 2012.
86. M. Rinnerthaler, J. Bischof, M. K. Streubel, A. Trost, and K. Richter, "Oxidative stress in aging human skin, " Biomolecules, vol. 5, no. 2, pp. 545-589, 2015.
87. D. Wang and R. N. Dubois, "Prostaglandins and cancer, " Gut, vol. 55, no. 1, pp. 115-122, 2006.
88. D. S. Micalizzi, S. M. Farabaugh, and H. L. Ford, "Epithelialmesenchymal transition in cancer: parallels between normal development and tumor progression, " Journal of Mammary Gland Biology and Neoplasia, vol. 15, no. 2, pp. 117-134, 2010.
89. C. Gustafson-Svärd, I. Lilja, O. Hallböök, and R. Sjödahl, "Cyclo-oxygenase and colon cancer: clues to the aspirin effect?" Annals of Medicine, vol. 29, no. 3, pp. 247-252, 1997.
90. M. K. Chung, J. Asgar, J. Lee, M. S. Shim, C. Dumler, and J. Y. Ro, "The role of TRPM2 in hydrogen peroxide-induced expression of inflammatory cytokine and chemokine in rat trigeminal ganglia, " Neuroscience, vol. 297, pp. 160-169, 2015.
91. R. D. Li, W. H. Kong, L. J. Qin, Z. M. Hua, and Z. W. Cheng, "ROS-induced ZNF580 expression: a key role for H2O2/NF-B signaling pathway in vascular endothelial inflammation, " Molecular and Cellular Biochemistry, vol. 359, no. 1-2, pp. 183-191, 2012.
92. J. A. Didonato, F. Mercurio, and M. Karin, "NF-B and the link between inflammation and cancer, " Immunological Reviews, vol. 246, no. 1, pp. 379-400, 2012.
93. K. L. Schwertfeger, M. K. Cowman, P. G. Telmer, E. A. Turley, and J. B. McCarthy, "Hyaluronan, inflammation, and breast cancer progression, " Frontiers in Immunology, vol. 6, article 236, 2015.
94. Y. Nishio, T. Gojoubori, Y. Kaneko, N. Shimizu, and M. Asano, "Cancer cell-derived IL-8 induces monocytic THP1 cells to secrete IL-8 via the mitogen-activated protein kinase pathway, " Tumor Biology, pp. 1-7, 2015.
95. M. Xin, X.-W. Dong, and X.-L. Guo, "Role of the interaction between galectin-3 and cell adhesion molecules in cancer metastasis, " Biomedicine and Pharmacotherapy, vol. 69, pp. 179-185, 2015.
96. N. V. Krakhmal, M. V. Zavyalova, E. V. Denisov, S. V. Vtorushin, and V. M. Perelmuter, "Cancer invasion: patterns and mechanisms, " Acta Naturae, vol. 7, no. 2, pp. 17-28, 2015.
97. J. Li, R. Fan, S. Zhao et al., "Reactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells, " International Journal of Molecular Sciences, vol. 12, no. 4, pp. 2434-2447, 2011.
98. P. Sun, Y. Mu, and S. Zhang, "A novel NF-B/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1, " Tumor Biology, vol. 35, no. 12, pp. 12721-12727, 2014.
99. R. Ahmad, P. K. Shihab, S. Jasem, and K. Behbehani, "FSL-1 induces MMP-9 production through TLR-2 and NF-B /AP-1 signaling pathways in monocytic THP-1 cells, " Cellular Physiology and Biochemistry, vol. 34, no. 3, pp. 929-942, 2014.
100. N. Tobar, V. Villar, and J. F. Santibanez, "ROS-NF? mediates TGF-1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion, " Molecular and Cellular Biochemistry, vol. 340, no. 1-2, pp. 195-202, 2010.
101. S. Textor, R. Accardi, T. Havlova et al., "NF-B-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interaction, " International Journal of Cancer, vol. 128, no. 5, pp. 1104-1113, 2011.
102. A. Keibel, V. Singh, and M. C. Sharma, "Inflammation, microenvironment, and the immune system in cancer progression, " Current Pharmaceutical Design, vol. 15, no. 17, pp. 1949-1955, 2009.
103. K. B. Marcu, M. Otero, E. Olivotto, R. M. Borzi, and M. B. Goldring, "NF-B signaling: multiple angles to target OA, " Current Drug Targets, vol. 11, no. 5, pp. 599-613, 2010.
104. X. Lu and Y. Kang, "Chemokine (C-C Motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone, " The Journal of Biological Chemistry, vol. 284, no. 42, pp. 29087-29096, 2009.
105. M. A. Chetram, A. S. Don-Salu-Hewage, and C. V. Hinton, "ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells, " Biochemical and Biophysical Research Communications, vol. 410, no. 2, pp. 195-200, 2011.
106. M. DeNiro, F. H. Al-Mohanna, O. Alsmadi, and F. A. Al-Mohanna, "The nexus between VEGF and NFB orchestrates a hypoxia-independent neovasculogenesis, " PLoS ONE, vol. 8, no. 3, Article ID e59021, 2013.
107. R. R. Langley and I. J. Fidler, "The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs, " International Journal of Cancer, vol. 128, no. 11, pp. 2527-2535, 2011.
108. J. J. Wamsley, M. Kumar, D. F. Allison et al., "Activin upregulation by NF-B is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer, " Cancer Research, vol. 75, no. 2, pp. 426-435, 2015.
109. K. T. Troppan, K. Schlick, A. Deutsch et al., "C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients, " British Journal of Cancer, vol. 111, no. 1, pp. 55-60, 2014.
110. P. Ren, D. Sun, D. Xin et al., "Serum amyloid A promotes osteosarcoma invasion via upregulating v3 integrin, " Molecular Medicine Reports, vol. 10, no. 6, pp. 3106-3112, 2014.
111. S. Hiratsuka, A. Watanabe, Y. Sakurai et al., "The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a premetastatic phase, " Nature Cell Biology, vol. 10, no. 11, pp. 1349-1355, 2008.
112. L. Ravenna, P. Sale, M. Di Vito et al., "Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma, " Prostate, vol. 69, no. 11, pp. 1245-1255, 2009.
113. M. Tafani, A. Russo, M. Di Vito et al., "Up-regulation of proinflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment, " Cancer Science, vol. 101, no. 4, pp. 1014-1023, 2010.
114. J. Strebovsky, P. Walker, and A. H. Dalpke, "Suppressor of cytokine signaling proteins as regulators of innate immune signaling, " Frontiers in Bioscience, vol. 17, no. 5, pp. 1627-1639, 2012.
115. J. Strebovsky, P. Walker, R. Lang, and A. H. Dalpke, "Suppressor of cytokine signaling 1 (SOCS1) limits NFB signaling by decreasing p65 stability within the cell nucleus, " The FASEB Journal, vol. 25, no. 3, pp. 863-874, 2011.
116. E. De Santis, M. Di Vito, G. A. Perrone et al., "Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells, " Biomedicine and Pharmacotherapy, vol. 67, no. 1, pp. 7-16, 2013.
117. R. H. Houtkooper, E. Pirinen, and J. Auwerx, "Sirtuins as regulators of metabolism and healthspan, " Nature Reviews Molecular Cell Biology, vol. 13, no. 4, pp. 225-238, 2012.
118. W. Dang, "The controversial world of sirtuins, " Drug Discovery Today Technologies, vol. 12, pp. e9-e17, 2014.
119. S. Rajendrasozhan, S.-R. Yang, V. L. Kinnula, and I. Rahman, "SIRT1, an anti-inflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease, " American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 8, pp. 861-870, 2008.
120. Z. Zhang, S. F. Lowry, L. Guarente, and B. Haimovich, "Roles of SIRT1 in the acute and restorative phases following induction of inflammation, " The Journal of Biological Chemistry, vol. 285, no. 53, pp. 41391-41401, 2010.
121. M. Dvir-Ginzberg, V. Gagarina, E. J. Lee, R. Booth, O. Gabay, and D. J. Hall, "Tumor necrosis factor-mediated cleavage and inactivation of sirT1 in human osteoarthritic chondrocytes, " Arthritis & Rheumatism, vol. 63, no. 8, pp. 2363-2373, 2011.
122. A. Chalkiadaki and L. Guarente, "High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction, " Cell Metabolism, vol. 16, no. 2, pp. 180-188, 2012.
123. A. Furukawa, S. Tada-Oikawa, S. Kawanishi, and S. Oikawa, "H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion, " Cellular Physiology and Biochemistry, vol. 20, no. 1-4, pp. 45-54, 2007.
124. N. Braidy, G. J. Guillemin, H. Mansour, T. Chan-Ling, A. Poljak, and R. Grant, "Age related changes inNAD+metabolism oxidative stress and sirt1 activity in wistar rats, " PLoS ONE, vol. 6, no. 4, Article ID e19194, 2011.
125. H. Massudi, R. Grant, N. Braidy, J. Guest, B. Farnsworth, and G. J. Guillemin, "Age-associated changes in oxidative stress and NAD+ metabolism in human tissue, " PLoS ONE, vol. 7, no. 7, Article ID e42357, 2012.
126. H. M. O'Hagan, W. Wang, S. Sen et al., "Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands, " Cancer Cell, vol. 20, no. 5, pp. 606-619, 2011.
127. J. B. Pillai, A. Isbatan, S.-I. Imai, and M. P. Gupta, "Poly(ADPribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2 deacetylase activity, " The Journal of Biological Chemistry, vol. 280, no. 52, pp. 43121-43130, 2005.
128. A. Kauppinen, T. Suuronen, J. Ojala, K. Kaarniranta, and A. Salminen, "Antagonistic crosstalk between NF-B and SIRT1 in the regulation of inflammation and metabolic disorders, " Cellular Signalling, vol. 25, no. 10, pp. 1939-1948, 2013.
129. Z. Ren, L. Wang, J. Cui et al., "Resveratrol inhibits NF-B signaling through suppression of p65 and IB kinase activities, " Pharmazie, vol. 68, no. 8, pp. 689-694, 2013.
130. J.-H. Lim, Y.-M. Lee, Y.-S. Chun, J. Chen, J.-E. Kim, and J.-W. Park, "Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha, " Molecular Cell, vol. 38, no. 6, pp. 864-878, 2010.
131. A. Laemmle, A. Lechleiter, V. Roh et al., "Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1 protein under hypoxic conditions, " PLoS ONE, vol. 7, no. 3, Article ID e33433, 2012.
132. F. Wang, M. Nguyen, F. X.-F. Qin, and Q. Tong, "SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction, " Aging Cell, vol. 6, no. 4, pp. 505-514, 2007.
133. A. S. Lee, Y. J. Jung, D. Kim et al., "SIRT2 ameliorates lipopolysaccharide-induced inflammation in macrophages, " Biochemical and Biophysical Research Communications, vol. 450, no. 4, pp. 1363-1369, 2014.
134. K. M. Rothgiesser, S. Erener, S. Waibel, B. Lüscher, and M. O. Hottiger, "SIRT2 regulates NF-B-dependent gene expression through deacetylation of p65 Lys310, " Journal of Cell Science, vol. 123, no. 24, pp. 4251-4258, 2010.
135. M. J. Kim, D. W. Kim, J. H. Park et al., "PEP-1-SIRT2 inhibits inflammatory response and oxidative stress-induced cell death via expression of antioxidant enzymes inmurinemacrophages, " Free Radical Biology and Medicine, vol. 63, pp. 432-445, 2013.
136. I. Grbesa, M. J. Pajares, E. Martínez-Terroba et al., "Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients, " PLoS ONE, vol. 10, no. 4, Article ID e0124670, 2015.
137. S. Singh, P. U. Kumar, S. Thakur et al., "Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells, " Tumor Biology, vol. 36, no. 8, pp. 6159-6171, 2015.
138. W. Xu, K. Jiang, M. Shen, Y. Qian, and Y. Peng, "SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A, " Biological Chemistry, vol. 396, no. 8, pp. 929-936, 2015.
139. L. Ma, W. Maruwge, A. Strambi et al., "SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth, " Cell Death & Disease, vol. 5, no. 10, Article IDe1483, 2014.
140. H. Nie, Y. Li, C. Wang et al., "SIRT2 plays a key role in both cell cycle regulation and cell survival of BV2 microglia, " International Journal of Physiology, Pathophysiology and Pharmacology, vol. 6, no. 3, pp. 166-171, 2014.
141. S. P. Divya, P. Pratheeshkumar, Y. Son et al., "Arsenic induces insulin resistance inmouse adipocytes andmyotubes via oxidative stress-regulated mitochondrial Sirt3-FOXO3a signaling pathway, " Toxicological Sciences, vol. 146, no. 2, pp. 290-300, 2015.
142. L. Zeng, Y. Yang, Y. Hu et al., "Age-related decrease in the mitochondrial sirtuin deacetylase Sirt3 expression associated with ROS accumulation in the auditory cortex of the mimetic aging rat model, " PLoS ONE, vol. 9, no. 2, Article ID e88019, 2014.
143. K. G. Cheung, L. K. Cole, B. Xiang et al., "Sirtuin-3 (SIRT3) protein attenuates doxorubicin-induced oxidative stress and improves mitochondrial respiration in H9c2 cardiomyocytes, " The Journal of Biological Chemistry, vol. 290, no. 17, pp. 10981-10993, 2015.
144. A. H.-H. Tseng, L.-H. Wu, S.-S. Shieh, and D. L. Wang, "SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia, " Biochemical Journal, vol. 464, no. 1, pp. 157-168, 2014.
145. L. Pellegrini, B. Pucci, L. Villanova et al., "SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH, " Cell Death & Differentiation, vol. 19, no. 11, pp. 1815-1825, 2012.
146. L. W. S. Finley, A. Carracedo, J. Lee et al., "SIRT3 opposes reprogramming of cancer cell metabolism through HIF1 destabilization, " Cancer Cell, vol. 19, no. 3, pp. 416-428, 2011.
147. M. C. Haigis, R. Mostoslavsky, K. M. Haigis et al., "SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic cells, " Cell, vol. 126, no. 5, pp. 941-954, 2006.
148. M. Verma, N. Shulga, and J. G. Pastorino, "Sirtuin-4 modulates sensitivity to induction of the mitochondrial permeability transition pore, " Biochimica et Biophysica Acta-Bioenergetics, vol. 1827, no. 1, pp. 38-49, 2013.
149. Y. Zhu, Y. Yan, D. R. Principe, X. Zou, A. Vassilopoulos, and D. Gius, "SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis, " Cancer & Metabolism, vol. 2, article 15, 2014.
150. S. M. Jeong, C. Xiao, L. W. S. Finley et al., "SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism, " Cancer Cell, vol. 23, no. 4, pp. 450-463, 2013.
151. S. M. Jeong, A. Lee, J. Lee, and M. C. Haigis, "SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma, "The Journal of Biological Chemistry, vol. 289, no. 7, pp. 4135-4144, 2014.
152. M. Miyo, H. Yamamoto, M. Konno et al., "Tumour-suppressive function of SIRT4 in human colorectal cancer, " British Journal of Cancer, vol. 113, no. 3, pp. 492-499, 2015.
153. Z.-F. Lin, H.-B. Xu, J.-Y. Wang et al., "SIRT5 desuccinylates and activates SOD1 to eliminate ROS, " Biochemical and Biophysical Research Communications, vol. 441, no. 1, pp. 191-195, 2013.
154. V. H. Villar, F. Merhi, M. Djavaheri-Mergny, and R. V. Durán, "Glutaminolysis and autophagy in cancer, " Autophagy, vol. 11, no. 8, pp. 1198-1208, 2015.
155. C.-C. Lai, P.-M. Lin, S.-F. Lin et al., "Altered expression of SIRT gene family in head and neck squamous cell carcinoma, " Tumor Biology, vol. 34, no. 3, pp. 1847-1854, 2013.
156. E. H. Shroff, L. S. Eberlin, V. M. Dang et al., "MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism, " Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 21, pp. 6539-6544, 2015.
157. L. Polletta, E. Vernucci, I. Carnevale et al., "SIRT5 regulation of ammonia-induced autophagy and mitophagy, " Autophagy, vol. 11, no. 2, pp. 253-270, 2015.
158. C. H. Eng and R. T. Abraham, "Glutaminolysis yields a metabolic by-product that stimulates autophagy, " Autophagy, vol. 6, no. 7, pp. 968-970, 2010.
159. R. Liu, H. Liu, Y. Ha, R. G. Tilton, and W. Zhang, "Oxidative stress induces endothelial cell senescence via downregulation of Sirt6, " BioMed Research International, vol. 2014, Article ID 902842, 13 pages, 2014.
160. J.-P. Etchegaray, L. Zhong, and R. Mostoslavsky, "The histone deacetylase SIRT6: at the crossroads between epigenetics, metabolism and disease, " Current Topics in Medicinal Chemistry, vol. 13, no. 23, pp. 2991-3000, 2013.
161. B. M. M. Zwaans and D. B. Lombard, "Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming, " Disease Models and Mechanisms, vol. 7, no. 9, pp. 1023-1032, 2014.
162. A. Maksin-Matveev, Y. Kanfi, E. Hochhauser, A. Isak, H. Y. Cohen, and A. Shainberg, "Sirtuin 6 protects the heart from hypoxic damage, " Experimental Cell Research, vol. 330, no. 1, pp. 81-90, 2015.
163. M. Lappas, "Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells, "Mediators of Inflammation, vol. 2012, Article ID597514, 11 pages, 2012.
164. H.-S. Lee, S.-O. Ka, S.-M. Lee, S.-I. Lee, J.-W. Park, and B.-H. Park, "Overexpression of sirtuin 6 suppresses inflammatory responses and bone destruction in mice with collagen-induced arthritis, " Arthritis and Rheumatism, vol. 65, no. 7, pp. 1776-1785, 2013.
165. Z. Xu, L. Zhang, W. Zhang et al., "SIRT6 rescues the age related decline in base excision repair in a PARP1-dependent manner, " Cell Cycle, vol. 14, no. 2, pp. 269-276, 2015.
166. X. Feng, J. Luo, M. Liu et al., "Sirtuin 6 promotes transforming growth factor-1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence, " Cancer Science, vol. 106, no. 5, pp. 559-566, 2015.
167. E. Ford, R. Voit, G. Liszt, C. Magin, I. Grummt, and L. Guarente, "Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription, " Genes & Development, vol. 20, no. 9, pp. 1075-1080, 2006.
168. S. Kiran, V. Oddi, and G. Ramakrishna, "Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response, " Experimental Cell Research, vol. 331, no. 1, pp. 123-141, 2015.
169. S. Malik, L. Villanova, S. Tanaka et al., "SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors, " Scientific Reports, vol. 5, article 9841, 2015.
170. O. Vakhrusheva, C. Smolka, P. Gajawada et al., "Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice, " Circulation Research, vol. 102, no. 6, pp. 703-710, 2008.
171. M. Gertz, G. T. T. Nguyen, F. Fischer et al., "A molecular mechanism for direct sirtuin activation by resveratrol, " PLoS ONE, vol. 7, no. 11, Article ID e49761, 2012.
172. S. Chung, H. Yao, S. Caito, J.-W. Hwang, G. Arunachalam, and I. Rahman, "Regulation of SIRT1 in cellular functions: role of polyphenols, " Archives of Biochemistry and Biophysics, vol. 501, no. 1, pp. 79-90, 2010.
173. C. Dallas, A. Gerbi, G. Tenca, F. Juchaux, and F.-X. Bernard, "Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMPphosphodiesterase (PDE), " Phytomedicine, vol. 15, no. 10, pp. 783-792, 2008.